Teva Settles Coreg Suit Against Dr. Reddy’s

Law360, New York (July 30, 2008, 12:00 AM EDT) -- Teva Pharmaceutical Industries Ltd. has resolved a suit seeking to block Dr. Reddy’s Laboratories Inc. from launching a generic version of GlaxoSmithKline Inc.'s congestive heart failure drug Coreg.

The parties’ settlement prompted the U.S. District Court for the District of New Jersey to dismiss the case without costs and without prejudice, Judge Garrett E. Brown Jr. said on Tuesday.

An attorney representing Teva informed the court earlier this month that its pending motion for leave to amend its complaint and the discovery issues raised could be...
To view the full article, register now.